<DOC>
	<DOCNO>NCT01530581</DOCNO>
	<brief_summary>This Randomized Multicentre study Comparing GCSF Mobilized Peripheral Blood GCSF stimulate Bone Marrow Patients undergo match sibling Transplantation Haematologic Malignancies .</brief_summary>
	<brief_title>Study Comparing G-CSF Mobilized Peripheral Blood G-CSF Stimulated Bone Marrow Patients Undergoing Matched Sibling Transplantation</brief_title>
	<detailed_description />
	<mesh_term>Neoplasms</mesh_term>
	<criteria>Recipient must 1 . Be age 16 65 year old 2 . Have one follow hematologic malignancy : Acute myeloid leukemia ( de novo , secondary therapy relate ) untreated 1st relapse remission evidence molecular relapse blast less 5 % Chronic myeloid leukemia chronic accelerate phase ( de novo therapy relate ) Myelodysplasia ( de novo therapy relate ) Other hematologic malignancy ( de novo therapy relate ) include limit : ALL ( CR 1 , CR2 CR3 ) , CLL , nonHodgkin 's lymphoma , Hodgkin 's lymphoma 3 . Must receive myeloablative condition regimen busulfan cyclophosphamide TBI cyclophosphamide myeloablative regimen approve Clinical Study Chair . ( Regimens contain ATG allow . ) 4 . Have HLAidentical sibling donor 5 . Meet transplant centre 's criterion myeloablative allogeneic transplantation* 6 . Have ECOG performance status 0 , 1 2 7 . Have give sign informed consent Donor must 1 . Be 18 year age old . ( Upper age limit discretion transplant physician collection centre . ) 2 . Be able undergo general anesthesia BM harvest peripheral blood collection per assessment transplant physician . ( If anesthetist ass donor randomization determines donor undergo general anesthesia , donor recipient withdrawn study . ) 3 . Be sibling recipient 4 . Be 6/6 HLA match recipient . HLA type serologic DNA methodology A B DNA methodology A B DNA methodology DRB1 ( intermediate resolution ) 5 . Have give sign informed consent Exclusion Criteria Recipient 1 . The recipient HIV antibody positive Donor 1 . The donor unable undergo general anesthesia , bone marrow harvest peripheral blood collection 2 . The donor pregnant breastfeeding time progenitor cell collection 3 . The donor history malignant disease within last 5 year current malignancy nonmelanomatous situ skin carcinoma cervical carcinoma situ 4 . The donor HIV antibody positive 5 . The donor know sensitivity E. coliderived product 6 . The donor recipient identical twin</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2016</verification_date>
</DOC>